Kymera Therapeutics, Inc. (KYMR)

86.26 +3.55 (+4.29%) USD  |  NASDAQ  |  May 06, 16:00
84.84 -1.42 (-1.65%) After-Hours: 06:31
More

Kymera Therapeutics Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Structure Therapeutics, Inc. Upgrade